TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Global Cosmetics News’ Week 42 review, covering October 2026, reported developments spanning acquisitions, sales, international retail expansion, manufacturing and digital marketing. The roundup also highlighted disputes over alleged unauthorised sales, trade delays and calls for stronger consumer protections; several deal and legal outcomes remain unresolved.
Global Cosmetics News’ Week 42 review reported a busy period for the global cosmetics and personal care industry, with major acquisitions and portfolio changes alongside retail expansion, manufacturing investment and legal disputes. The roundup, covering October 2026, also described trade delays and consumer-protection concerns, underscoring the range of commercial and regulatory pressures facing beauty companies.
Corporate transactions were among the week’s most consequential developments. Galderma agreed to acquire ZO Skin Health for US$1.5 billion, a move that would expand its physician-dispensed skincare portfolio. Bogart sold its 47-store Israeli cosmetics retail subsidiary for €5.8 million. The European Union approved Kimberly-Clark’s proposed US$40 billion acquisition of Kenvue following an agreement to divest assets, according to the review.
Financial and commercial updates included higher third-quarter sales across LVMH’s beauty operations and Sephora network. Shein reported UK sales of £2.58 billion, up 26 percent, and overtook Asos, the review said. e.l.f. Beauty said it planned to put a US$50 million tariff refund toward pricing and marketing initiatives. Executives at Beauty Tech Group sold £6 million in shares after the company’s strong initial public offering performance, as described by the source.
Retailers and brands also pursued growth in international markets. CJ Olive Young expanded K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong; Nykaa and L’Oréal introduced a Kiehl’s skincare launch in India; and Kiko Milano set out plans to double its Indian store footprint by the end of 2026. In the United States, Bluemercury relaunched its Lune+Aster makeup brand with a refreshed identity and larger assortment.
Investment and innovation featured elsewhere in the roundup. Estée Lauder invested €5.7 million in advanced manufacturing at its Belgian facility, while L’Oréal Travel Retail and Avolta partnered on sustainability initiatives in duty-free beauty. e.l.f. Cosmetics launched a virtual experience on ZEPETO, and Bandai expanded Tamagotchi licensing into cosmetics in Asian markets. An AI-generated concept involving Hunter and Rhode Beauty prompted questions about unofficial brand collaborations and generative technology in marketing.
Beauty Growth Meets New Risks
The developments show how beauty companies are pursuing growth through acquisitions, new markets and digital channels while managing operational and reputational risks. Transactions such as Galderma’s proposed purchase of ZO Skin Health could change portfolio positions in skincare, while Sephora partnerships and store expansion plans offer brands routes to reach consumers in Asia and India.
At the same time, trade friction, intellectual-property disputes and consumer protection can affect costs and market access. Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales, according to the review; the allegation is not a court finding. French cosmetics exporters also faced customs delays in China. These issues matter to companies reliant on cross-border supply and distribution, as well as consumers seeking clarity about product authenticity and standards.
professional skincare products for dermatologists
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Week Across Beauty Markets
The review grouped developments across corporate strategy, retail, manufacturing, technology and policy rather than focusing on one company or market. It also noted leadership changes: John Demsey left Gap Inc. as the retailer expanded its beauty operations; ELEMIS co-founder Sean Harrington joined Lempriere Wells as a partner; and Bluemercury appointed Stacie Borteck Dattner as head of merchandising. Makeup artist Isamaya Ffrench departed her namesake brand, with its future described as uncertain.
Regulatory and industry standards were another thread. Superdrug called for stronger regulation of the UK aesthetics industry, while Kering and LVMH strengthened their model protection charter with updated standards. Separately, Amazon was reported to be in discussions to acquire AI start-up Decart for approximately US$7 billion; that potential transaction is outside beauty but reflects the wider technology activity included in the weekly review.
Deals and Disputes Still Open
The source is a weekly roundup and does not provide detailed documentation for each announcement. It does not specify the expected closing dates or remaining conditions for the Galderma–ZO Skin Health deal, or the divested assets tied to EU approval of Kimberly-Clark’s Kenvue acquisition. Amazon’s reported discussions with Decart do not establish that an agreement has been reached.
The status and response to Shiseido’s lawsuit, the length and scope of customs delays affecting French exporters in China, and the commercial effect of those delays were not detailed. The review also did not quantify the results expected from e.l.f.’s planned tariff-refund spending or provide a timetable for the regulatory changes sought by Superdrug. The AI-generated Hunter and Rhode concept was described as raising questions, but the review did not establish that it was an authorised collaboration.
Deal Closings and Market Plans
Readers can watch for further filings or company statements on the proposed acquisitions, including any conditions, completion dates or changes to deal terms. The next visible milestones in retail include Kiko Milano’s stated goal of doubling its Indian footprint by the end of 2026 and the continued rollout of CJ Olive Young products through Sephora locations in Southeast Asia and Hong Kong.
Further updates may clarify the Shiseido-Shein dispute, customs conditions for French exporters, and whether calls for stronger UK aesthetics regulation lead to policy action. Companies’ follow-up disclosures will also show how manufacturing investment, sustainability partnerships and digital beauty projects progress beyond the announcements covered in this week’s review.
Key Questions
What was the main development in the Week 42 review?
The review recorded multiple developments across global beauty, led by acquisitions and portfolio changes, alongside retail expansion, investment, legal disputes and regulatory concerns. It was a roundup, not a single transaction announcement.
Did Galderma complete its purchase of ZO Skin Health?
No completion was reported. The source says Galderma agreed to acquire ZO Skin Health for US$1.5 billion; it does not give a closing date or confirm that the transaction has closed.
What happened in the Shiseido-Shein dispute?
Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales, according to the review. The report does not give the court’s response or the outcome, and the allegation should not be treated as proven.
Which international retail plans were reported?
CJ Olive Young expanded K-beauty distribution through Sephora in Southeast Asia and Hong Kong. The review also covered a Kiehl’s launch in India through Nykaa and L’Oréal, and Kiko Milano’s plan to double its Indian retail footprint by the end of 2026.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
